1. Home
  2. SILC vs SLGL Comparison

SILC vs SLGL Comparison

Compare SILC & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicom Ltd

SILC

Silicom Ltd

HOLD

Current Price

$48.58

Market Cap

267.6M

Sector

Technology

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$59.71

Market Cap

254.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SILC
SLGL
Founded
1987
1997
Country
Israel
Israel
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
267.6M
254.1M
IPO Year
2002
2016

Fundamental Metrics

Financial Performance
Metric
SILC
SLGL
Price
$48.58
$59.71
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$110.00
AVG Volume (30 Days)
164.7K
51.7K
Earning Date
04-30-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.17
N/A
Revenue Next Year
$12.28
$223.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.34
$27.00
52 Week High
$52.95
$97.97

Technical Indicators

Market Signals
Indicator
SILC
SLGL
Relative Strength Index (RSI) 60.80 32.12
Support Level $38.57 $48.26
Resistance Level $52.52 $81.02
Average True Range (ATR) 2.56 2.59
MACD 0.88 -0.44
Stochastic Oscillator 86.45 18.38

Price Performance

Historical Comparison
SILC
SLGL

About SILC Silicom Ltd

Silicom Ltd is engaged in designing, manufacturing, marketing, and supporting high-performance networking and data infrastructure solutions for a broad range of servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, Switches, Edge AI Solutions, Edge Networking Accessories, 4G 5G Products, FPGA-Based Cards, and Others. Its geographic areas are the USA, North America - other, Israel, Europe, and Asia-Pacific. It derives a majority of its revenue from the USA.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: